Cell-associated adhesion molecules in hemodialysis

International Journal of Immunopathology and Pharmacology

Volumn 10, Issue 1, 1997, Pages 37-44

  Bonomini, M ^a   Stuard, S ^a   Albertazzi, A ^a,b  

^a UNIVERSITY OF CHIETI   (Italy)

^b SAN CAMILLO DE LELLIS HOSPITAL   (Italy)

Author keywords

adhesion molecules; CD15s; hemodialysis biocompatibility; P selectin

Indexed keywords

CD15 ANTIGEN; INTEGRIN; PADGEM PROTEIN;

CELL ADHESION; ENDOTHELIUM; HEMODIALYSIS; HUMAN; NEUTROPHIL; PRIORITY JOURNAL; REVIEW; THROMBOCYTE AGGREGATION;

EID: 0030912832     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. Bonomini V. Introducing the biology of bioincompatibility in dialysis. 1991. Nephrol. Dial. Transplant. Suppl. 2:1
2. Klinkmann H. and J. Vienken. 1995. Membranes for dialysis. Nephrol. Dial. Tranplant. 10 (Suppl. 3):39
3. Henderson L.W., A.K. Cheung and D.E. Chenoweth. 1983. Choosing a membrane. Am J Kidney Dis 3:5
4. Bergstrom J. 1989. Hemodialysis: does the membrane matter? Semin. Dial. 2:7
5. Falkenhagen D., T. Bosch, G. Brown, B. Schmidt, M. Holtz, U. Baurmeister, H. Gurland and H. Klinkmann. 1987. A clinical study on different cellulosic membranes. Nephrol. Dial. Transplant. 2:537
6. Ivanovich P., D. Chenoweth, R. Schmidt, H. Klinkniann, L. Boxer, H. Jacob and D. Hammerschmidt. 1983. Symptoms and activation of granulocytes and complement with two dialysis membranes. Kidney Int. 24:758
7. Woffindin C., N.A. Hoenich and J.N.S. Matthews. 1992. Cellulose-based haemodialysis membranes: biocompatibility and functional performance compared. Nephrol. Dial. Transplant. 7:340
8. Mujais S.K. 1988. New membranes: the promise of ingenuity. Int. J. Artif. Organs 11:219
9. Ivanovich P. and S.K. Mujais. 1992. Should cuprophan membranes continue to be used for chronic hemodialysis. Semin. Dial. 5:115
10. Salem M., P. Ivanovich and S.K. Mujais. 1993. Biocompatibility of dialysis membranes. Contrib. Nephrol. 103:55
11. Ward R.A., R.M. Schaefer, D. Falkenhagen, M.S. Joshuca, A. Heidland, H. Klinkmann and H.J. Gurland. 1993. Biocompatibility of a new high-permeability modified cellulose membrane for haemodialysis. Nephrol. Dial. Transplant. 8:47
12. Horl W.H., R.M. Schacfer and A. Heidland. 1985. Effect of different dialyzes, on protease and proteinase inhibitors during hemodialysis. Am. J. Nephrol. 5:320
13. Blumenstein M., H.W.L. Ziegler-Heitbrock, B. Schiller, B. Schmidt, R.A. Ward and H.J. Gurland. 1990. Differential activation of monocytes in haemodialysis patients exposed to different types of membranes. Scand. J. Immunol. 31:183
14. Bonomini V., L. Colì, G. Feliciangeli, G. Mosconi and M.P. Scolari. 1995. Long-term results: cellulosic vs. synthetic membranes. Contrib. Nephrol. 113:120
15. Hakim R.M. 1993. Clinical implications of hemodialysis membrane biocompatibility. Kidney Int. 44:484
16. Hakin R.M., D.T. Fearon and J.M. Lazarus. 1984. Biocompatibility of dialysis membranes: effects of chronic complement activation. Kidney Int. 26:194
17. Craddock P.R., J. Fern, K.L. Brigham, R.S. Kronenberg and H.S. Jacobs. 1977. Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N. Engl. J. Med. 296:769
18. Craddock P.R., J. Ferh, A.P. Dalmasso, K.L. Brigham and H.S. Jacobs. 1977. Hemodialysis leukopenia: pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J. Clin. Invest. 59:879
19. Pereira B.J.H. and C.A. Dinarcllo. 1994. Production of cytokines and cytokine inhibitory proteins in patients on dialysis. Nephrol. Dial. Transplant. 9 (Suppl. 2):60
20. Schulman G., R. Arias, S. Diehl et al. 1986. A comparison of the ability of dialysis membranes to activate Hageman factor. Kidney Int. 29:224
21. Mahiout A., A. Jorres, H. Meinhold et al. 1986. Prostaglandin production and extracorporeal complement activation by dialyzer membranes. Trans. Am. Soc. Artif. Intern. Organs 32:88
22. Mahiout A., A. Jorres, G. Schultze et al. 1989. Eicosanoid release as laboratory indicator of biocompatibility. Artif. Organs 13:251
23. Schmidt B. and Mujais S.K. 1995. Evaluation of dialysis membrane-blood compatibility: experimental methods. Contrib. Nephrol. 113:32
24. Craddock P.R., D.E. Hammerschmidt, J.G. White, A.P. Dalmasso and H.S. Jacobs. 1977. Complement (C5a)-induced granulocyte aggregation in vitro: a possible mechanism for complement-mediated leukostasis and leukopenia. J. Clin. Invest. 60:260
25. McGregor R.R. 1977. Granulocyte adherence changes induced by hemodialysis, endotoxin, epinephrin, and glucocorticoids. Ann. Intern. Med. 36:35
26. 2 integrins are required for neutrophil degranulation induced by hemodialysis membranes. Kidney Int. 43:649
27. Ruoslahti E. and M.D. Pierschbacher. 1987. New perspectives in cell adhesion: RGD and integrins. Science 238:491
28. Springer T.A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 76:301
29. Springer T.A. 1990. Adhesion receptors of the immune system. Nature 346:425
30. Ruoslahti E. 1991. Integrins. J. Clin. Invest. 87:1
31. Butcher E.C. 1991. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 67:1033
32. Lawrence M.B. and T.A. Springer. 1991. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell 65:859
33. Gearing A.J.H. and W. Newrrian. 1993. Circulating adhesion molecules in disease. Immunol. Today 14:506
34. Zimmerman G.A., S.M. Prescott and T.M. McIntyre. 1992. Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol. Today 13:93
35. Adams D.A. and S. Shaw. 1994. Leukocyte-endothelial interactions and regulation of leukocyte migration. Lancet 343:831
36. Rot A. 1992. Endothelial cell binding of NAP-l/IL-8: role in neutrophil emigration. Immunol. Today 13:291
37. Kaplow L.S. and J.A. Goffinet. 1968. Profound neutropenia during the early phase of hemodialysis. JAMA 203:1135
38. Arnaout M.A., R.M. Hakim, R.F. Todd, N. Dana and H.N Colten. 1985. Increased expression of an adhesionpromoting surface glycoprotein in the granulocytopenia of hemodialysis. N. Engl. J. Med. 312:457
39. Tielemans C.L., J.P.C. Delville, C.P. Husson, P. Madhoun, A.M. Lambrechts, M. Goldman and J.L. Vanherweghem. 1993. Adhesion molecules and leukocyte common antigen on monocytes and granulocytes during hemodialysis. Clin. Nephrol 39:158
40. Alvarez V., R. Pulido, M.R. Campanero, V. Paraiso, M.O. de Landazuri and F. Sanchez-Madrid. 1991. Differentially regulated cell surface expression of leukocyte adhesion receptors on neutrophilis. Kidney Int. 40:899
41. Thylen P., J. Lundahl, E. Fernvik, J. Hed, S.B. Svenson and S.H. Jacobson. 1992. Mobilization of an intracellular glycoprotein (Mac-1) on monocytes and granulocytes during hemodialysis. Am. J. Nephrol. 12:393
42. Combe C., M. Pourtein, V. de Précigout, A. Baquey, D. Morel, L. Potaux, P. Vinccndeau, J.H. Bézian and M. Aparicio. 1994. Granulocyte activation and adhesion molecules during hemodialysis with cuprophane and a high-flux biocompatible membrane. Am. J. Kidney Dis. 24:437
43. Himmelfarb J., P. Zaoui and R. Hakim. 1992. Modulation of granulocyte LAM-1 and Mac-1 during dialysis. A prospective, randomized controlled trial. Kidney Int. 41:388
44. Stuard S., M.P. Carreno, J.L. Poignet, A. Albertazzi and N. Haeffner-Cavaillon. 1995. A major role for CD62P/CD 15s interaction in leukocyte margination during hemodialysis. Kidney Int. 48:43
45. Stuard S., M.P. Carreno, N. Haeffner-Cavallion, M. Bonomini and A. Albertazzi. 1995. Ruolo delle molecole di adesione sulla leucopenia durante emodialisi con membrane di Cuprophane. Giorn. It. Nefrol. 12 (4):243
46. Ćarreno M.P., S. Stuard, M. Bonomini, N. Settefrati, C. Tetta, A. Albcrtazzi, N. Haeffner, Cavaillion. 1996. Soluble and cell-associated adhesion molecules as early markers of bioincompatibility. Nephrol. Dial. Transplant. 11:2248
47. Bonomini M., S. Stuard, N. Settcfrati, P. Santarelli, C. Tetta and A. Albertazzi. 1996. A synthetically modified cellulose (SMC) membrane for haemodialysis (HD): biocompatibility and functional characterization. Nephrol. Dial. Transplant. 11:A233 (abstract)
48. Varki A. 1994. Selectins ligands. Proc. Natl. Acad. Sci. USA 91:7390
49. Etzioni A., M. Frydman, S. Pollack, I. Avidor, M.L. Phillips, J.C. Paulson and R. Gershoni-Baruch. 1992. Brief report: Recurrent severe infections caused by a novel leukocyte adhesion deficiency. N. Engl. J. Med. 327:1789
50. McEver R.P., J.H. Beckstead, K.L. Moore, L. Marshall-Calsonand D.F. Bainton. 1989. GMP-140, aplatelet alpha granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J. Clin. Invest. 84:92
51. Gawaz M.P. and R.A. Ward. 1991. Effect of hemodialysis on platelet derived thrombospondin. Kidney Int. 40:257.
52. Hakim R.M. and A.I. Schafer. 1985. Hemodialysis-associated platelet activation and thrombocytopenia. Am. J. Med. 78:575
53. Faint R.W. 1992. Platelet-neutrophil interactions: Their significance. Blood Rev. 6:83.
54. Rinder H.M., J.L. Bonan, C.S. Rinder, K.A. Ault and B.R. Smith. 1991. Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood 78:1760
55. Rinder H.M., J.L. Bonan, C.S. Rinder, K.A. Ault and B.R. Smith. 1991. Dynamics of leukocyte platelet adhesion in whole blood. Blood 78:1730
56. Bazzoni G.,E. Dcjana and A. Del Maschio. 1991. Platelet neutrophil interactions. Possible relevance in the pathogenesis of thrombosis and inflammation. Haeinatologica 76:491
57. Stuard S., N. Settefrati, P. Santarelli, M.P. Carreno, N. Haeffner-Cavaillon, M. Bonomini and A. Albertazzi. 1995. Attivazione piastrinica e formazione di microaggregati piastrine leucociti durante emodialisi. Giorn. It. Nefrol. 12 (5):311
58. Larsen E., A. Celi, G.E. Gilbert, B.A. Furie, J.K. Erban, R. Bonfanti, D.D. Wagner and B.C. Furie. 1989. PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 59:305
59. Gawaz M.P., S.K. Mujais, B. Schimdt and H.J. Gurland. 1994. Platelet-leukocyte aggregation during hemodialysis. Kidney Int. 46:489
60. Ware J.A. and D.D. Heistad. 1993. Platelet endothelium interactions. N. Eng. J. Med. 328:628
61. Spangenberg P., H. Redlich, I. Bergmann, W. Losche, M. Gotzrath and B. Kehrel. 1993. The platelet glycoprotein IIb/IIIa complex is involved in the adhesion of activated platelets to leukocytes. Thromb. Haemost. 70:514
62. Evangelista V., P. Piccardoni, J.G. White JG, G. de Gaetano and C. Cerletti. 1993. Cathepsin-G dependent platelet stimulation by activated polymorphonuclear leukocytes and its inhibition by antiproteinases: Role of P-selectin-mediated cell-cell adhesion. Blood 81:2947
63. Brady H.R., A. Papayianni and C.N. Serhan. 1994. Leukocyte adhesion promotes biosynthesis of lipoxygenase products by transcellular routes. Kidney Int. 45 (Suppl 45):S90
64. Nagata K.,T. Tsuji, N. Todoroki, Y. Katagiri, K. Tanoue, H. Yamazaki, N. Hanai and T. Irimura. 1993. Activated platelets induce Superoxide anion release by monocytes and neutrophils through P-selectin. J. Immunol. 151:3267
65. Himmelfarb J., R.M. Hakim, D.G. Holbrook, D.A. Leeber and K.A. Ault. 1992. Detection of granulocyte reactive oxygen species production in whole blood using flow citometry. Cytometry 13:83
66. Himmelfarb J., KA. Ault, D. Holbrook, D.A. Leeber and R.M. Hakim. 1993. Intradialytic granulocyte reactive oxygen species production: A prospective, crossover trial. J. Am. Soc. Nephrol. 4:178
67. Rosenkranz A.R., E. Templ, O. Traindl, H. Heinzl and G.J. Zlabinger. 1994. Reactive oxygen product formation by human neutrophils as an early marker for biocompatibility of dialysis membrane. Clin. Exp. Immunol. 98:300
68. Bonomini M., S. Stuard, M.P. Carreno, N. Settefrati, P. Santarelli, N. Haeffner-Cavaillon and A. Albertazzi. Neutrophil reactive oxygen species production during hemodialysis: role of activated platelet adhesion to neutrophils through P-selectin. Nephron (in press)
69. Himmelfarb J., E. McGonagle, D. Holbrook and C. Toth. 1995. Soluble complement receptor 1 inhibits both complement and granulocyte activation during ex vivo hemodialysis. J. Lab. Clin. Med. 126:392
70. Jacobs A.A., R.A. Ward, S.R. Wellhausen and K.R. McLeish. 1989. Polymorphonuclear leukocyte function during hemodialysis. Relationship to complement activation. Nephron 52:119
71. Palabrica T., R. Lobb , B.C. Furie, M. Aronovitz, C. Benjamin, Y.M. Hsu, S.A. Sajer, B. Furie. 1992. Leukocyte accumulation promoting fibrin deposition is mediated in vitro by P-selectin on aderent platelets. Nature 359:848
72. Patel K.D., G.A. Zimmermann, S.M. Prescott, R.P. McEver and T.M. Mclntyre. 1991. Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J. Cell. Biol. 112:749
73. Weiss S.J., J. Young, A.F. LoBuglio, A. Slivka and N.F. Nimer. 1981. Role of hydrogen peroxide in neutrophilmediated destruction of cultured endothelial cells. J. Clin. Invest. 68:714.
74. Martin W.J. 1984. Neutrophils kill pulmonary endothelial cells by a hydrogen-peroxide dependent pathway. An in vitro model of neutrophil-mediated lung injury. Am. Rev. Respir. Dis. 130:209
75. Malech H.L., J.I. Gallin. 1987. Neutrophils in human diseases. N. Engl. J. Med. 317:687
76. Yagi K. 1986. A biochemical approach to atherogenesis. Trends Biochem. Sci. 11:18
77. McCord J.M. 1985. Oxygen-derived free radicals in postischemic tissue injury. N. Engl. J. Med. 312:159
78. Richard M.J., J. Arnaud, C. Jurkovitz, T. Hachachet, H. Meftahi, F. Laporte, M. Foret, A. Farrier and D. Cordonnier. 1991. Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. Nephron 57:10
79. Stuard S., M. Bonomini, P. Santarelli, M.P. Carreno, N. Settefrati, C. Tetta, R. Gervasio, N. Haeffner-Cavaillon and A. Albertazzi. 1996. Espressione cellulare e livelli plasmatici delle molecole di adesione durante emodialisi con membrane sintetiche. Giorn. It. Nefrol. 13 (3):175
80. Schulman G., A. Fago, A. Gung, K. Badr and R. Hakim. 1991. Complement activation retards resolution of ischemic renal failure in the rat. Kidney Int 40:1069
81. Cappelliere-Blandin C., T. Delaveau and B. Descamps-Latscha. 1991. Structural modifications of human beta 2-microglobulin treated with oxygen-derived radicals. Biocliem. J. 277:175